Dr Steve Burnell was appointed managing director of Tenmile, an Australian healthtech venture capital company owned by Tattarang, in 2022. Dr Burnell's professional experience spans research, philanthropy, strategy consulting, M&A, and operating global businesses in fields as diverse as marine ecology, digital health, and precision oncology.
Prior to his current role, he managed a global business, led M&A and established a new informatics and real-world data business for Roche-Genentech. He remains a strategic advisor to Minderoo Foundation where he has led initiatives focused on COVID-19, Cancer, and Ocean Genomics amongst others. He holds a B.Sc. (Hons.) in Biology and a Ph.D. in Population Biology from the University of Sydney.
Steve Burnell
Follow
Get notifications in MyBN when activity occurs.
Person Activity
![]() |
NEW ROLE: Executive Chair, Tenmile, Tattarang | 21 Feb 2024 |
![]() |
NEWS: Tagged in State, VCs drive healthtech push | 10 Aug 2023 |
![]() |
NEWS: Tagged in Funds call gains on stronger equities | 26 Jul 2023 |
![]() |
NEWS: Tagged in Healthech focus for new Forrest VC fund | 15 Aug 2022 |
![]() |
NEW ROLE: Executive Chair, Tenmile | 15 Aug 2022 |